$0.032

Want access to our research and new buy ideas?

Take a free 15 day trial - no credit card required.

Start your free trial now

ACG General Information

AtCor Medical Holdings Limited
ACG
http://www.atcormedical.com
Health Care Equipment
9
281

ACG Current Share Price+

Current Price $0.032
Open $0.032
High $0.032
Low $0.032
Last Close $0.032
Volume 75000
Price Movement - ( No change )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

ACG Company Overview

Business Description

AtCor Medical Holdings Limited (ACG) is an Australia-based company that is a developer and marketer of the SphygmoCor system which measures central blood pressures and arterial stiffness non-invasively.

ACG Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2017 A -4.36 -2.00 0.00% 0.00 0.00 0.00% 0.0%
2016 A -4.81 -2.40 0.00% 0.00 0.00 0.00% 0.0%
2015 A -1.44 -0.90 0.00% 0.00 0.00 0.00% 0.0%

ACG Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2015 A 2016 A 2017 A 2015 A 2016 A 2017 A 2015 A 2016 A 2017 A
AtCor Medical (ACG) $9M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Cochlear (COH) $10,030M 0.1790 0.1263 0.1858 44.7957 39.7736 33.5405 1.55% 1.75% 2.06%
Fisher & Paykel Hlth (FPH) $6,792M 0.3370 0.0040 0.2069 39.3318 39.1763 32.4597 1.50% 1.78% 2.16%
Impedimed (IPD) $265M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
ResMed (RMD) $16,733M 0.0041 0.3575 0.0501 34.1998 25.1936 23.9910 1.49% 1.78% 1.92%

ACG Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 5.61 0.00
Market 1.03 15.70 1.58 1.14
Sector 1.23 19.00 2.60 2.07

ACG Directors

Name Position Start Date
Mr Craig Cooper Chief Executive Officer, Executive Director 1 Dec 2017
Mr Donal Paul O'Dwyer Non-Executive Chairman, Non-Executive Director 9 Nov 2005
Mr Niall Cairns Non-Executive Director 20 Dec 2017
Mr David Lionel Brookes Non-Executive Director 4 Nov 2008
Mr Randall King Nelson Non-Executive Director 13 Nov 2015

ACG Management

Name Position
Peter L Manley Chief Finance Officer,Company Secretary
D T Kurschinski Senior Vice President & General Manager, AtCor Medical Inc.
M R Harding Vice President, Global Marketing & International Sales, AtCor Medical Pty Ltd.

ACG Substantial Shareholders

Holding Name
15,470,000 (5.50%) Cb Co Pty Ltd

ACG Calendar of Events

Date Event
26 October 2018 Report (Annual)
30 August 2018 Report (Prelim)
23 February 2018 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.